BioCentury
ARTICLE | Clinical News

Vistide data

March 18, 1996 8:00 AM UTC

Enrollment of new patients in a Phase II/III trial run by SOCA (Studies of the Ocular Complications of AIDS) was halted following statistically significant preliminary results in delaying progression of CMV retinitis at either of two doses. The decision to halt the trial was made after enrolling 64 of a projected 90 patients. ...